SEC Form D filing
Symbiotic Capital EB Parallel Fund, L.P.
Biotech · Regulation D 506(b) · CA · Filed March 11, 2025
Offering amount
Undisclosed
Exemption
Reg D 506(b)
Issuer state
CA
Filing date
March 11, 2025
Signature date
—
CIK
0002013515
Summary
Symbiotic Capital Life Science fund; no offering amount but clear healthcare/biotech focus.
Source
FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.